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Abstract
Background: By analysing the data of the intensive care unit (ICU) component of the German national nosocomial
infection surveillance system (KISS) during the last ten years, we have observed a steady increase in the MRSA rates
(proportions) from 2001 to 2005 and only a slight decrease from 2006 to 2010. The objective of this study was to
investigate the development of the incidence density of nosocomial MRSA infections because this is the crucial
outcome for patients.
Findings: Data from 103 ICUs with ongoing participation during the observation period were included. The
pooled incidence density of nosocomial MRSA infections decreased significantly from 0.37 per 1000 patient days in
2001 to 0.15 per 1000 patient days in 2010 (RR = 0.40; CI95 0.29-0.55). This decrease was proportional to the
significant decrease of all HCAI during the same time period (RR = 0.61; CI95 0.58-0.65).
Conclusions: The results underline the need to concentrate infection control activities on measures to control
HCAI in general rather than focusing too much on specific MRSA prevention measures. MRSA rates (proportions)
are not a very useful indicator of the situation.
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Findings
Methicillin resistant S. aureus (MRSA) is the major focus
of public awareness of healthcare-associated infection
(HCAI) problems in many countries and surveillance
should support the work toward decreasing nosocomial
MRSA infections. However, by analysing the data of the
intensive care unit (ICU) component of the German
national nosocomial infection surveillance system (KISS),
we have observed a steady increase in the MRSA rate as
a percentage of nosocomial MRSA infections among all
nosocomial S. aureus infections from 2001 to 2005 and
only a slight decrease in the period from 2006 to 2010.
The objective of this study was to investigate the develop-
ment of the incidence density of nosocomial MRSA
infections during the observation period, because this is
the crucial outcome for patients.
The ICU surveillance method used in KISS is almost
identical to the method used by the National Healthcare
Surveillance Network (NHSN) for surveillance of HCAI
in ICUs [1], [2]. Participation in KISS is voluntary and
results are handled confidentially. HCAI are mainly regis-
tered by infection control practitioners but also by physi-
cians. They are trained in KISS methodology and in
applying CDC definitions for HCAI. The number of par-
ticipating ICUs has increased from year to year. Up to
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2004, the ICUs received their data twice a year to provide
feedback and encourage infection control activities; since
2005 they have had the opportunity to analyse their data
whenever they want, due to the introduction of a web-
based data management system. In the case of an HCAI,
up to four pathogens probably responsible for the infec-
tion can be recorded. As well as their HCAI rates, the
ICUs also receive a list with their case patients and the
pathogens probably responsible.
The ICU KISS data from January 2001 to December
2010 that were used for this analysis focused on micro-
biologically-confirmed primary bloodstream infections,
X-ray-confirmed nosocomial pneumonia and nosocomial
urinary tract infections accordingly because the defini-
tions for these infection types did not change during the
observation period in KISS. Only those ICUs that pro-
vided data for at least 3 months per year during the
entire study period were included. The MRSA rate (pro-
portion of nosocomial MRSA/nosocomial S. aureus
infections) and the incidence densities of nosocomial
Methicillin susceptible S. aureus (MSSA) infections and
nosocomial MRSA infections (both per 1000 patient
days) were calculated. Relative risks (RR) with 95% confi-
dence intervals were determined to compare the yearly
pooled means of nosocomial MRSA infection incidence
densities. In addition, the development of all HCAI in
general was described by calculating RR and 95% confi-
dence intervals to compare the yearly pooled means of all
HCAI incidence densities.
Data from 103 ICUs, about 1 million patients with
about 3.5 million patient days and a total of 20,504 HCAI
were included. Among the HCAI were 2,026 nosocomial
MSSA infections and 921 nosocomial MRSA infections
(Table 1 and 2). The pooled mean MRSA rate (nosoco-
mial MRSA infections/nosocomial S. aureus infections)
increased from 2001 to 2005 and decreased slightly until
2010 compared to the starting point. However, the
pooled incidence density of nosocomial MRSA infections
decreased significantly from 0.37 per 1000 patient days in
2001 to 0.15 per 1000 patient days in 2010 (RR = 0.40;
CI95 0.29-0.55) (Figure 1). This decrease was propor-
tional to the significant decrease of all HCAI during the
same time period (RR = 0.61; CI95 0.58-0.65) (Figure 1).
However, despite a general trend of relative unchanged
proportion of MRSA among nosocomial S.aureus infection
during the last 10 years, the participating ICUs were able
to significantly decrease the incidence of nosocomial
MRSA and MSSA infections by the same proportion
(60%) through surveillance of nosocomial infections, feed-
back and appropriate intervention measures, whereas the
overall HCAI incidence was decreased only by 39%. This
development in KISS ICUs is in accordance with the
development of the incidence of nosocomial MRSA infec-
tions in other countries. For example, US intensive care
units observed a 49.6% decrease in the MRSA central line
associated bloodstream infection (BSI) incidence in the
period from 1997 to 2007 [3] and French intensive care
units in the Paris area achieved a 59% decrease inf the
MRSA burden from 1993 to 2007 [4].However, it is neces-
sary to interpret the data carefully, because there are
indeed some limitations. Firstly, the sensitivity of diagnos-
ing HCAI may have changed during the study period. A
decreasing rate of microbiology reports would lead to a
decreasing incidence density of nosocomial MRSA infec-
tions. However, the annual proportion of HCAI with
microbiology reports was 90.8% in 2001 and 89.4% in
2010. Secondly, the severity of illness of ICU patients may
have changed. If ventilator utilization rates are taken as a
surrogate parameter, this is not the case, as these rates
were 42.3% in 2001 and 42.7% in 2010. Thirdly, CDC defi-
nitions for BSI and pneumonia changed during the obser-
vation period. However, by focusing on microbiologically-
confirmed BSI and X-ray confirmed pneumonia only,
instead of including all BSI and pneumonia cases, this
should not have had an influence.
This significant decrease of HCAI MRSA infections
was masked in Germany because the public only looked
at the MRSA rate and did not recognize the significant
decrease in the incidence of MRSA infections, at least in
the group of KISS ICUs. The concentration on the pro-
portion of MRSA and other multidrug resistant pathogen
instead of surveying the incidence of MDR pathogens
may lead to less awareness of the need for the prevention
of HCAI in general. Other nosocomial pathogens may
lead to similar or even higher attributable morbidity and
mortality. Our results therefore underline the importance
of concentrating on measures to control HCAI in gen-
eral, rather than focusing too much on specific MRSA
prevention measures.
Table 1 Characteristics of 103 ICUs with continuous
participation in ICU-KISS from 2001 to 2010
Parameter No. (IQR; %)





other speciality 12 (11.7%)
Type of hospital
university hospital ICUs 17 (16.5%)
teaching hospital ICUs 56 (54.4%)
non academic hospital ICUs 30 (29.1%)
Size of ICU (median number of beds) 11 (IQR 9-14)
Size of Hospital (median number of beds) 500 (IQR 315-1000)
ICU, intensive care unit; No., number; IQR, interquartile range.
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2001 322990 42.3 290 120 29.3 0.90 0.37 1 = ref 7.56 1 = ref
2002 332215 41.7 252 107 29.8 0.76 0.32 0.87 (0.67-1.13) 6.74 0.89 (0.84-0.94)
2003 338819 42.1 221 101 31.4 0.65 0.30 0.8 (0.62-1.05) 6.66 0.88 (0.83-0.93)
2004 343513 42.8 230 93 28.8 0.67 0.27 0.73 (0.56-0.96) 5.80 0.77 (0.072-0.81)
2005 360684 42.9 221 135 37.9 0.61 0.37 1.01 (0.79-1.29) 6.46 0.85 (0.81-0.90)
2006 353148 42.5 207 89 30.1 0.59 0.25 0.68 0.52-0.89) 5.65 0.75 (0.70-0.79)
2007 363476 42.4 167 70 29.5 0.46 0.19 0.52 (0.39-0.70) 5.02 0.66 (0.62-0.71)
2008 372463 43.1 150 77 33.9 0.40 0.21 0.56 (0.42-0.74) 5.04 0.67 (0.63-0.71)
2009 371865 42.9 150 72 32.4 0.40 0.19 0.52 (0.39-0.70) 4.89 0.65 (0.61-0.69)
2010 380173 44.1 138 57 29.2 0.36 0.15 0.40 (0.29-0.55) 4.63 0.61 (0.58-0.65)
total 3539346 42.7 2026 921 31.3 0.57 0.26 5.80
MSSA, Methicillin susceptible S.aureus; MRSA, Methicillin resistant S.aureus,;*nosocomial infections focused on microbiologically-confirmed primary bloodstream
infections, X-ray-confirmed nosocomial pneumonia and nosocomial urinary tract infections
Figure 1 Incidence densities of nosocomial infections with MRSA and MSSA and all nosocomial infections. NI, nosocomial infections;
MSSA, Methicillin sensitive S. aureus; MRSA, Methicillin resistant S.aureus, focused on microbiologically-confirmed primary bloodstream infections,
X-ray-confirmed nosocomial pneumonia and nosocomial urinary tract infections.
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